Skip to main content

Abbott Laboratories (NYSE: ABT) Investor Securities Class Action Lawsuit 08/31/2022

  • If you purchased a significant amount of shares of Abbott Laboratories (NYSE: ABT) between February 19, 2021 and June 8, 2022, and / or if you purchased any NYSE: ABT shares prior to February 2021 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: October 31, 2022. NYSE: ABT investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

August 31, 2022 - An investor in shares of Abbott Laboratories (NYSE: ABT) filed a lawsuit in the U.S. District Court for the Northern District of Illinois over alleged violations of Federal Securities Laws by Abbott Laboratories in connection with certain allegedly false and misleading statements made between February 19, 2021 and June 8, 2022. Chicago, IL based Abbott Laboratories, ...

You must register (for free) or login to view the entire case.